Dettagli del prodotto
Luogo di origine: CINA
Marca: Orsin
Certificazione: ISO 13485
Numero di modello: Attivatore del coagulo di gel
Termini di trasporto & di pagamento
Quantità di ordine minimo: 100/PC
Prezzo: negoziabile
Tempi di consegna: 1-4 settimane
Termini di pagamento: L/C, D/A, D/P, T/T, Western Union
Capacità di alimentazione: 20 milioni/PC/falena
Comportamento: |
Forte tolleranza alla temperatura |
Ordine di esempio: |
Disponibile |
Etichetta del tubo: |
Etichetta bianca |
Ordini batch misti: |
Supportato |
Grado sottovuoto: |
Pressione negativa |
Attività piastrinica: |
Stabilità mantenuta |
Proprietà: |
Durabile e affidabile |
Materiale di chiusura: |
Tappo di gomma sintetico |
Tubo specializzato: |
Tubo di attivatore di coaguli |
Capacità: |
può essere personalizzato |
Dimensione del tubo: |
Dimensioni del tubo personalizzate |
Merito: |
Protezione dell'integrità del campione |
Comportamento: |
Forte tolleranza alla temperatura |
Ordine di esempio: |
Disponibile |
Etichetta del tubo: |
Etichetta bianca |
Ordini batch misti: |
Supportato |
Grado sottovuoto: |
Pressione negativa |
Attività piastrinica: |
Stabilità mantenuta |
Proprietà: |
Durabile e affidabile |
Materiale di chiusura: |
Tappo di gomma sintetico |
Tubo specializzato: |
Tubo di attivatore di coaguli |
Capacità: |
può essere personalizzato |
Dimensione del tubo: |
Dimensioni del tubo personalizzate |
Merito: |
Protezione dell'integrità del campione |
The Red Clot Activator Tube (commonly known as the "Red Top Tube") is a core consumable for clinical serum testing. Its wall is coated with clot activators to accelerate blood coagulation. Primary applications include:
Emergency biochemical testing: Cardiac enzyme panels, liver/kidney function, electrolytes (K⁺/Na⁺/Cl⁻), and other time-sensitive assays
Immunological and serological analysis: Thyroid function, tumor markers, infectious disease antibody screening (e.g., HIV)
Metabolic and therapeutic drug monitoring: Blood glucose (requires complementary gray-top glycolytic inhibitor tubes), therapeutic drug monitoring (TDM)
Its core value lies in reducing clotting time to 15–20 minutes (vs. ≥60 minutes for natural clotting), significantly improving testing efficiency.
Key innovations and advantages of the red clot activator tube:
Feature | Performance Benefit |
---|---|
Vascular-mimetic Silicone Coating | Silicone-treated walls prevent cell adhesion, eliminating hemolysis or pseudohyperkalemia during centrifugation |
Uniform Spray Clot Activation | Nano-scale spray coating ensures full blood-activator contact, accelerating clotting by 3–4× (deep coagulation in 15 min) |
High-Purity Serum Separation | Transparent serum post-centrifugation (3,500–4,000 rpm); fibrin residue rate <0.1%, eliminating instrument probe clogging |
Broad-Temperature Adaptability | Maintains efficacy at 0–37°C; below 16°C, increase inversions to sustain performance |
Operational compliance is critical for accuracy. Strictly adhere to:
Mixing Protocol: Immediately invert tube 5–8 times at 180° after collection to ensure full blood-activator contact and prevent fibrin formation.
Temperature Control:
Ambient temperature <20°C: Increase inversions to 8–10 times or use a 36°C water bath.
Centrifuge at 25°C to avoid gelatinous clots.
Clotting Time: Allow 15–20 minutes for complete coagulation before centrifugation (premature spinning causes fibrin threads).
Storage & Shelf Life:
Refrigerate opened tubes at 4°C; use within 1 week.
Discard if activators show granulation, odor, or discoloration.
Solutions for common issues:
Fibrin Threads/Gelatinous Clot:
Cause: Incomplete clotting or premature centrifugation.
Resolution: Extend room-temperature standing time to 30 min; re-centrifuge. For recurring cases, check activator coating uniformity.
Mild Hemolysis:
Cause: Insufficient mixing in cold environments or excessive mechanical agitation.
Resolution: Use inversion mixing (not shaking); pre-warm tubes to 25°C in cold conditions.
Insufficient Serum Yield:
Cause: Underfilled tube (e.g., <2mL in a 3mL tube) or vacuum loss.
Resolution: Replace tube; verify needle seal integrity.
Wall Adhesion/Cell Residue:
Cause: Silicone coating failure or inadequate centrifugation (<3,500 rpm).
Resolution: Centrifuge at 4,000 rpm × 10 min; use tubes from qualified batches.
5. Basic Specifications
Parameter | Specification |
---|---|
Volume | Standard: 1mL-10mL (larger volumes for multi-test panels) |
Material | Glass (heat-resistant) or PET plastic (shatterproof); Ø13–16mm × H75–100mm |
Clot Activator | Spray-dried silica composite (enzyme-free to avoid immunoassay interference) |
Centrifugation | 3,500–4,000 rpm for 5–10 min; gel-barrier tubes tolerate up to 5,000 rpm |
Packaging | 100 tubes/box or 1,800 tubes/carton |
The red clot activator tube is the preferred choice for emergency and biochemical testing due to its rapid clotting, high-purity serum, and broad temperature adaptability. Optimal performance requires strict adherence to mixing protocols, temperature control, and centrifugation timing to avoid fibrin residue or hemolysis. For high-precision tests (e.g., tumor markers), gel-barrier activator tubes (gold cap) are recommended for superior serum quality.
This translation maintains technical accuracy while adapting terminology to international medical standards (e.g., CLSI guidelines). Key metrics (rpm, temperature ranges) and proprietary terms (brand names) are preserved per industry conventions.